PURPOSE: For patients with cancer who are older than 65 years, the 2018 ASCO Guideline recommends geriatric assessment (GA) be performed. However, there are limited data on providers' practices using GA. Therefore, ASCO's Geriatric Oncology Task Force conducted a survey of providers to assess practice patterns and barriers to GA. METHODS: Cancer providers treating adult patients including those ≥ 65 years completed an online survey. Questions included those asking about awareness of ASCO's Geriatric Oncology Guideline (2018), use of validated GA tools, and perceived barriers to using GA. Descriptive statistics and statistical comparisons between those aware of the Guideline and those who were not were conducted. Statistical significance was set at P < .05. RESULTS: Participants (N = 1,277) responded between April 5 and June 5, 2019. Approximately half (53%) reported awareness of the Guideline. The most frequently used GA tools, among those aware of the Guideline and those who were not, assessed functional status (69% v 50%; P < .001) and falls (62% v 45%; P < .001). Remaining tools were used < 50% of the time, including tools assessing weight loss, comorbidities, cognition, life expectancy, chemotherapy toxicity, mood, and noncancer mortality risk. GA use was two to four times higher among those who are aware of the Guideline. The most frequent barriers for those who reported being Guideline aware were lack of resources, specifically time (81.7%) and staff (77.0%). In comparison, those who were unaware of the Guideline most often reported the following barriers: lack of knowledge or training (78.4%), lack of awareness about tools (75.2%), and uncertainty about use of tools (75.0%). CONCLUSION: Among providers caring for older adults, 52% were aware of the ASCO Guideline. Some domains were assessed frequently (eg, function, falls), whereas other domains were assessed rarely (eg, mood, cognition). Guideline awareness was associated with two to four times increased use of GA and differing perceived barriers. Interventions facilitating Guideline-consistent implementation will require various strategies to change behavior.
PURPOSE: For patients with cancer who are older than 65 years, the 2018 ASCO Guideline recommends geriatric assessment (GA) be performed. However, there are limited data on providers' practices using GA. Therefore, ASCO's Geriatric Oncology Task Force conducted a survey of providers to assess practice patterns and barriers to GA. METHODS: Cancer providers treating adult patients including those ≥ 65 years completed an online survey. Questions included those asking about awareness of ASCO's Geriatric Oncology Guideline (2018), use of validated GA tools, and perceived barriers to using GA. Descriptive statistics and statistical comparisons between those aware of the Guideline and those who were not were conducted. Statistical significance was set at P < .05. RESULTS: Participants (N = 1,277) responded between April 5 and June 5, 2019. Approximately half (53%) reported awareness of the Guideline. The most frequently used GA tools, among those aware of the Guideline and those who were not, assessed functional status (69% v 50%; P < .001) and falls (62% v 45%; P < .001). Remaining tools were used < 50% of the time, including tools assessing weight loss, comorbidities, cognition, life expectancy, chemotherapy toxicity, mood, and noncancer mortality risk. GA use was two to four times higher among those who are aware of the Guideline. The most frequent barriers for those who reported being Guideline aware were lack of resources, specifically time (81.7%) and staff (77.0%). In comparison, those who were unaware of the Guideline most often reported the following barriers: lack of knowledge or training (78.4%), lack of awareness about tools (75.2%), and uncertainty about use of tools (75.0%). CONCLUSION: Among providers caring for older adults, 52% were aware of the ASCO Guideline. Some domains were assessed frequently (eg, function, falls), whereas other domains were assessed rarely (eg, mood, cognition). Guideline awareness was associated with two to four times increased use of GA and differing perceived barriers. Interventions facilitating Guideline-consistent implementation will require various strategies to change behavior.
Authors: Erin B Moth; Belinda E Kiely; Natalie Stefanic; Vasikaran Naganathan; Andrew Martin; Peter Grimison; Martin R Stockler; Philip Beale; Prunella Blinman Journal: J Geriatr Oncol Date: 2018-11-28 Impact factor: 3.599
Authors: Enrique Soto-Perez-de-Celis; Nienke A de Glas; Tina Hsu; Ravindran Kanesvaran; Christopher Steer; Ana Patricia Navarrete-Reyes; Nicolo Matteo Luca Battisti; Yanin Chavarri-Guerra; Anita O'Donovan; Jose Alberto Avila-Funes; Arti Hurria Journal: J Geriatr Oncol Date: 2017-06-20 Impact factor: 3.599
Authors: Ronald J Maggiore; William Dale; Arti Hurria; Heidi D Klepin; Andrew Chapman; Efrat Dotan; Supriya G Mohile; Arash Naeim; Ajeet Gajra; Mary K Buss Journal: J Oncol Pract Date: 2017-08-24 Impact factor: 3.840
Authors: C Kenis; L Decoster; J Flamaing; P R Debruyne; I De Groof; C Focan; F Cornélis; V Verschaeve; C Bachmann; D Bron; S Luce; G Debugne; H Van den Bulck; J-C Goeminne; D Schrijvers; K Geboers; B Petit; C Langenaeken; R Van Rijswijk; P Specenier; G Jerusalem; J-P Praet; K Vandenborre; J-P Lobelle; M Lycke; K Milisen; H Wildiers Journal: Ann Oncol Date: 2018-09-01 Impact factor: 32.976
Authors: Darryl Outlaw; Maya Abdallah; Luiz A Gil-Jr; Smith Giri; Tina Hsu; Jessica L Krok-Schoen; Gabor Liposits; Tânia Madureira; Joana Marinho; Ishwaria M Subbiah; Gina Tuch; Grant R Williams Journal: Semin Radiat Oncol Date: 2022-04 Impact factor: 5.934
Authors: Courtney P Williams; Amy Davidoff; Michael T Halpern; Michelle Mollica; Kathleen Castro; Benjamin Allaire; Janet S de Moor Journal: JCO Oncol Pract Date: 2022-08
Authors: Ashley E Rosko; Christopher Steer; Leana Cabrera Chien; Jason Zittel; Andrew Artz; Selina Chow; Elana Plotkin; William Dale; Rawad Elias; Andrew E Chapman Journal: J Geriatr Oncol Date: 2021-04-16 Impact factor: 3.599
Authors: Ajeet Gajra; Marjorie E Zettler; Kelly A Miller; John G Frownfelter; John Showalter; Amy W Valley; Sanya Sharma; Shreenath Sridharan; Jonathan K Kish; Sibel Blau Journal: JCO Oncol Pract Date: 2021-09-10
Authors: Erin E Kent; Eliza M Park; William A Wood; Ashley Leak Bryant; Michelle A Mollica Journal: J Clin Oncol Date: 2021-05-27 Impact factor: 50.717
Authors: Jeanne S Mandelblatt; Tim A Ahles; Marc E Lippman; Claudine Isaacs; Lucile Adams-Campbell; Andrew J Saykin; Harvey J Cohen; Judith Carroll Journal: JAMA Oncol Date: 2021-11-01 Impact factor: 31.777